Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-17

FDA Approved: FLECAINIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for flecainide acetate from Hikma Pharmaceuticals USA Inc., expanding or authorizing changes to this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flecainide acetate (flecainide acetate)

Snippet

SUPPL AP for FLECAINIDE ACETATE (FLECAINIDE ACETATE)